Drug Profile
Lecozotan
Alternative Names: Lecozotan hydrochloride; SRA-333Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Wyeth
- Class Antidementias; Dioxanes; Nitriles; Nootropics; Piperazines; Pyridines; Small molecules
- Mechanism of Action 5-HT1A serotonin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 16 Oct 2009 Wyeth has been acquired by Pfizer
- 30 Sep 2009 Discontinued - Phase-II for Alzheimer's disease in Argentina (PO)
- 30 Sep 2009 Discontinued - Phase-II for Alzheimer's disease in Australia (PO)